arrow
R

Ruud Ubink

byondis b.v.
H指数:20
被引数:2,159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
2023-04-177
OAAI
BYON4228, an antagonistic SIRPα mAb with a unique and favorable preclinical profile compared to three comparator SIRPa mAbs
2023-04-040
PRE
BYON4228, A PAN-ALLELIC SIRPa BLOCKING ANTIBODY WITH A FAVORABLE PRE-CLINICAL SAFETY PROFILE, ENHANCES ANTI-TUMOR IMMUNITY IN VITRO AND IN VIVO
2022-11-070
OA
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice
2018-11-0232
OAAI
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers
2015-03-09161
OAAI
Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform
2014-11-03154
OAAI